Apyx Operating Cycle from 2010 to 2026

APYX Stock  USD 3.57  0.21  5.56%   
Apyx Medical Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle will likely drop to 165.45 in 2026. During the period from 2010 to 2026, Apyx Medical Operating Cycle regression line of annual values had r-squared of  0.16 and arithmetic mean of  252.36. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
238.29
Current Value
165.45
Quarterly Volatility
98.31831657
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Apyx Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apyx Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 724.3 K, Interest Expense of 7.1 M or Selling General Administrative of 52.1 M, as well as many indicators such as Price To Sales Ratio of 1.28, Dividend Yield of 0.0 or PTB Ratio of 4.32. Apyx financial statements analysis is a perfect complement when working with Apyx Medical Valuation or Volatility modules.
  
Build AI portfolio with Apyx Stock
Check out the analysis of Apyx Medical Correlation against competitors.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.
The evolution of Operating Cycle for Apyx Medical provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Apyx Medical compares to historical norms and industry peers.

Latest Apyx Medical's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Apyx Medical over the last few years. It is Apyx Medical's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apyx Medical's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Apyx Operating Cycle Regression Statistics

Arithmetic Mean252.36
Geometric Mean234.64
Coefficient Of Variation38.96
Mean Deviation79.23
Median238.29
Standard Deviation98.32
Sample Variance9,666
Range322
R-Value0.40
Mean Square Error8,639
R-Squared0.16
Significance0.11
Slope7.84
Total Sum of Squares154,664

Apyx Operating Cycle History

2026 165.45
2025 238.29
2024 264.77
2023 292.6
2022 429.61
2021 325.07
2020 373.1

About Apyx Medical Financial Statements

Apyx Medical investors use historical fundamental indicators, such as Apyx Medical's Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apyx Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 238.29  165.45 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.